Latest Investments News

APA Group has agreed to sell its 20% stake in the Allgas gas distribution network to Stonepeak affiliates, marking another step in its strategy to simplify operations and focus on core growth areas.

Bailador Technology Investments has increased the valuations of its portfolio companies Updoc and PropHero, driving a notable uplift in net tangible assets per share and signaling strong early performance in FY26.

Buru Energy is actively pursuing funding for its 2026 drilling campaign to validate resources at the Rafael Gas Project, aiming for a Final Investment Decision in the second half of 2026 and first cashflow by 2028.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

ActivEX Limited has raised $100,000 through a strategic share placement to Business Victor Investments, aiming to accelerate its exploration projects and strengthen working capital.

Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.

Hawsons Iron Ltd has declared a JORC-compliant Probable Ore Reserve of 2.3 billion tonnes and completed a positive Pre-Feasibility Study supporting a 26-year, 12Mtpa magnetite concentrate project in New South Wales.

Elders Limited has updated its dividend details for the half-year ending September 2025, declaring a fully franked 18 cents per share dividend payable in December, alongside a discounted dividend reinvestment plan.

RocketDNA has secured approximately A$1 million in new orders from major mining clients, expanding its autonomous drone deployments and software services across Australia and Africa.

DEXUS has announced an estimated ordinary distribution of AUD 0.193 per unit for the six months ending December 2025, marking a steady income stream for investors ahead of the new year.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.